Dexamethazone versus ketamine in interscalene block in patients undergoing arthroscopic shoulder surgery. A randomized double-blinded study.

Dexamethazone versus ketamine in interscalene block in patients undergoing arthroscopic shoulder surgery. A randomized double-blinded study. - Dexamethazone versus ketamine in interscalene block in arthroscopic shoulder surgery.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000025386

Enrollment

Registered

2017-01-15

Start date

2016-07-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The recruiting cases is going on

Interventions

First group receive interscalene block with bupivacaine 0.25%plus 8mg dexamethazone (Group D), other group receive interscalene block with bupivacaine 0.25% plus 50mg ketamine (Group K).

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: ASA I &II arthroscopic shoulder surgery

Exclusion criteria

Exclusion criteria: Obstructive pulmonary disease Diabetes Neuropathy Contralateral diaphragmatic paralysis A history of allergic reaction to any of the study drugs Epilepsy. Neuromuscular disease. Hematological disorders.

Design outcomes

Primary

Measure	Time frame
compare first request of analgesia between dexamethazone and ketamine in interscalene block in patients undergoing arthroscopic shoulder surgery.	—

Countries

Africa

Contacts

Public ContactDr Khaled Elbahrawy

Mansoura university hospital Anesthesia

Elbahrawy_khaled@yahoo.com0020502202515

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026